Status:
COMPLETED
Comparative Bioavailability Study of Film-coated Tablet and Granule Formulations of RG1662
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Healthy Volunteer
Eligibility:
All Genders
18-60 years
Phase:
PHASE1
Brief Summary
This study will compare the pharmacokinetic performance of film-coated tablet and granule formulations of RG1662 under fed and fasted conditions in healthy volunteers. A randomized, four-period, four-...
Eligibility Criteria
Inclusion
- Male or female volunteers, 18 to 60 years of age, inclusive
Exclusion
- A history of epilepsy, convulsions or significant head injury
- Any other clinically relevant abnormalities, concomitant diseases or ongoing medical conditions
Key Trial Info
Start Date :
August 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT02194244
Start Date
August 1 2014
End Date
August 1 2014
Last Update
November 2 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Leeds, United Kingdom, LS2 9LH